{"id":1183,"date":"2026-08-30T23:43:13","date_gmt":"2026-08-30T23:43:13","guid":{"rendered":"https:\/\/vistaralabs.ca\/semax-vs-selank\/"},"modified":"2026-09-04T08:25:27","modified_gmt":"2026-09-04T08:25:27","slug":"semax-vs-selank","status":"publish","type":"post","link":"https:\/\/vistaralabs.ca\/fr\/semax-vs-selank\/","title":{"rendered":"Semax ou Selank : ce qui les distingue r\u00e9ellement"},"content":{"rendered":"<p><strong><a href=\"https:\/\/vistaralabs.ca\/buy-semax-canada\/\">Semax<\/a> and <a href=\"https:\/\/vistaralabs.ca\/buy-selank-canada\/\">Selank<\/a> get compared constantly, and the comparison is slightly misleading.<\/strong> They came out of the same Russian institute, they were built using the same stabilising trick, and they are sold side by side everywhere. But they are derived from unrelated parent molecules and are studied around different systems. Asking which is better is a bit like asking whether a throttle is better than a brake.<\/p>\n<h2>Findings<\/h2>\n<ul class=\"vl-findings\">\n<li>Same Russian institute, same stabilising design, but <strong>different parent molecules and different research territories<\/strong>.<\/li>\n<li>Semax is the activating side: BDNF, plasticity, stroke and attention research.<\/li>\n<li>Selank is the calming side: anxiety and stress research via the GABA system.<\/li>\n<li>They are studied together because they complement rather than overlap.<\/li>\n<\/ul>\n<h2>The short version<\/h2>\n<table>\n<thead>\n<tr>\n<th><\/th>\n<th>Semax<\/th>\n<th>Selank<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td><strong>Derived from<\/strong><\/td>\n<td>ACTH(4\u201310) fragment<\/td>\n<td>Tuftsin<\/td>\n<\/tr>\n<tr>\n<td><strong>Parent molecule&#8217;s day job<\/strong><\/td>\n<td>Adrenal hormone signalling<\/td>\n<td>Immune signalling<\/td>\n<\/tr>\n<tr>\n<td><strong>Main research theme<\/strong><\/td>\n<td>BDNF, neurotrophic signalling, plasticity<\/td>\n<td>GABAergic modulation, enkephalinase inhibition<\/td>\n<\/tr>\n<tr>\n<td><strong>Studied in<\/strong><\/td>\n<td>Stroke, brain injury, attention and memory models<\/td>\n<td>Anxiety and stress models<\/td>\n<\/tr>\n<tr>\n<td><strong>Loose characterisation<\/strong><\/td>\n<td>The activating side<\/td>\n<td>The calming side<\/td>\n<\/tr>\n<tr>\n<td><strong>Russian clinical status<\/strong><\/td>\n<td>Registered; essential medicines list<\/td>\n<td>In clinical use since the 1990s<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>What they genuinely share<\/h2>\n<p>Three things, and they are the reason the two are permanently linked:<\/p>\n<ul>\n<li><strong>The same institute.<\/strong> Both came out of Russian neuropeptide research programmes in the same era.<\/li>\n<li><strong>The same stabilising design.<\/strong> Each takes a fragile natural fragment and attaches a <strong>Pro-Gly-Pro<\/strong> sequence to protect it from the enzymes that would otherwise destroy it within minutes. That is a design decision, not a mechanism.<\/li>\n<li><strong>The same delivery question.<\/strong> Both are studied predominantly as intranasal formulations, for the same reason \u2014 peptides cross the blood\u2013brain barrier poorly.<\/li>\n<\/ul>\n<p>What they do <em>not<\/em> share is a receptor, a pathway, or a research literature. The shared surname is chemistry, not biology.<\/p>\n<h2>Where they diverge<\/h2>\n<h3>Semax: the plasticity arm<\/h3>\n<p>The consistent thread through the Semax literature is <strong>BDNF<\/strong> \u2014 brain-derived neurotrophic factor \u2014 and its TrkB receptor. BDNF is the protein most closely associated in neuroscience with synaptic plasticity, meaning the brain&#8217;s capacity to strengthen and reorganise connections. The Semax work sits on top of an original programme aimed at ischaemic stroke, which is why a surprising amount of it is neuroprotection research rather than cognitive-enhancement research.<\/p>\n<h3>Selank: the inhibitory arm<\/h3>\n<p>Selank&#8217;s literature centres on <strong>GABAergic modulation<\/strong> \u2014 GABA being the brain&#8217;s main inhibitory signal \u2014 and on inhibiting the enzymes that break down enkephalins, the body&#8217;s own short opioid-like signalling peptides. The clinical use in Russia is for anxiety rather than cognition. Its defining design claim was anxiolytic activity without sedation, which is the specific thing that made it interesting.<\/p>\n<h2>Why they are studied together<\/h2>\n<p>The pairing has a community nickname \u2014 the Russian nootropic stack \u2014 and the rationale behind it is the same rationale behind any sensible <a href=\"https:\/\/vistaralabs.ca\/peptide-stacks-canada\/\">peptide stack<\/a>: the two compounds address different, non-overlapping parts of one system.<\/p>\n<p>Put simply, one is studied around excitatory and plasticity signalling and the other around inhibitory and stress signalling. Compounds that pull on separate levers are more interesting to study together than compounds that pull on the same one, where you cannot tell which is responsible for what you observe. Pairing two GABAergic compounds tells you very little; pairing a plasticity-oriented compound with an inhibitory one at least gives you two distinguishable variables.<\/p>\n<div class=\"vl-note\">\n<p>This is a rationale, not a result. There is very little published work studying the two <em>in combination<\/em> \u2014 the pairing is inferred from what is known about each separately. Anyone presenting the stack as a validated protocol is going beyond the evidence.<\/p>\n<\/div>\n<h2>A third component: Cerebrolysin<\/h2>\n<p>Where a stack extends beyond the two, the usual third is <a href=\"https:\/\/vistaralabs.ca\/cerebrolysin-60mg\/\">Cerebrolysin<\/a> \u2014 a mixture of low-molecular-weight peptides derived from porcine brain tissue, studied as a broad neurotrophic-factor mimetic.<\/p>\n<p>It is worth knowing because it changes the evidence picture. Unusually for this category, <a href=\"https:\/\/vistaralabs.ca\/buy-cerebrolysin-canada\/\">Cerebrolysin<\/a> has been through real international randomised controlled trials in dementia, stroke and traumatic brain injury. The results across those trials are genuinely mixed and the compound remains contested \u2014 but the trials exist, were run outside Russia, and are published in journals anyone can read. That is more than can be said for most of the category.<\/p>\n<h2>Which one, if you are only picking one<\/h2>\n<p>This is a research-design question rather than a shopping question, and the honest answer is that it depends on what is being investigated. Semax is the one with the neurotrophic and plasticity literature behind it; Selank is the one with the anxiolytic and stress literature. Neither is a stronger compound than the other in any general sense \u2014 they have barely been compared head to head, because they were never developed to do the same job.<\/p>\n<h2>The evidence caveat that applies to both<\/h2>\n<p>Both compounds have a genuine clinical history, and both have far less independent verification than any approved Western medicine. The trials are largely Russian, published mostly in Russian-language journals. Neither is approved in Canada, and Health Canada has assessed neither for safety or efficacy.<\/p>\n<p>That combination \u2014 real clinical history, limited independent scrutiny \u2014 is unusual, and it is the single most important thing to understand about this pair. It is also why the marketing around them tends to be so overheated in both directions.<\/p>\n<p>The reason no Western sponsor has taken either compound through trials is not scientific but economic, and it applies across most of this category: <a href=\"https:\/\/vistaralabs.ca\/why-peptides-not-fda-approved\/\">why peptides like these never reach approval<\/a>.<\/p>\n<div class=\"vl-note\">\n<p>Vistara Labs stocks <a href=\"https:\/\/vistaralabs.ca\/semax-10mg\/\">Semax 10&nbsp;mg<\/a>, <a href=\"https:\/\/vistaralabs.ca\/selank-10mg\/\">Selank 10&nbsp;mg<\/a> and <a href=\"https:\/\/vistaralabs.ca\/cerebrolysin-60mg\/\">Cerebrolysin 60&nbsp;mg<\/a> as individual research vials, and together in a <a href=\"https:\/\/vistaralabs.ca\/stacks\/\">research stack<\/a>. All shipped from within Canada to every province.<\/p>\n<\/div>\n<h2>Frequently asked questions<\/h2>\n<h3>What is the difference between Semax and Selank?<\/h3>\n<p>Semax is derived from an ACTH fragment and is studied around BDNF, neurotrophic signalling and plasticity. Selank is derived from tuftsin and is studied around GABAergic modulation and anxiety models. They share a research lineage and a stabilising design, not a mechanism.<\/p>\n<h3>Can Semax and Selank be studied together?<\/h3>\n<p>They are frequently paired in research settings because they address separate, non-overlapping systems. However, there is very little published work on the combination itself \u2014 the rationale is inferred from what is known about each compound individually.<\/p>\n<h3>Which is better, Semax or Selank?<\/h3>\n<p>Neither, in any general sense. They were developed for different purposes and have barely been compared directly. Which is more relevant depends entirely on what is being investigated.<\/p>\n<h3>Is Selank a sedative and Semax a stimulant?<\/h3>\n<p>Neither description is accurate. Selank was specifically designed for anxiolytic activity without sedation, and Semax has no stimulant-class mechanism. The activating and calming characterisations are loose shorthand for which systems each is studied around.<\/p>\n<h3>Are Semax and Selank approved in Canada?<\/h3>\n<p>No. Neither holds Canadian marketing authorisation and Health Canada has not assessed either compound. Both are supplied as research materials.<\/p>\n<p><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What is the difference between Semax and Selank?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Semax is derived from an ACTH fragment and is studied around BDNF, neurotrophic signalling and plasticity. Selank is derived from tuftsin and is studied around GABAergic modulation and anxiety models. They share a research lineage and a stabilising design, not a mechanism.\"}},{\"@type\":\"Question\",\"name\":\"Can Semax and Selank be studied together?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"They are frequently paired in research settings because they address separate, non-overlapping systems. However, there is very little published work on the combination itself - the rationale is inferred from what is known about each compound individually.\"}},{\"@type\":\"Question\",\"name\":\"Which is better, Semax or Selank?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Neither, in any general sense. They were developed for different purposes and have barely been compared directly. Which is more relevant depends entirely on what is being investigated.\"}},{\"@type\":\"Question\",\"name\":\"Is Selank a sedative and Semax a stimulant?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Neither description is accurate. Selank was specifically designed for anxiolytic activity without sedation, and Semax has no stimulant-class mechanism. The activating and calming characterisations are loose shorthand for which systems each is studied around.\"}},{\"@type\":\"Question\",\"name\":\"Are Semax and Selank approved in Canada?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"No. Neither holds Canadian marketing authorisation and Health Canada has not assessed either compound. Both are supplied as research materials.\"}}]}<\/script><\/p>\n<div class=\"vl-ruo\">\n<p>All products supplied by Vistara Labs are intended for laboratory research use only. They are not drugs, are not approved for human or veterinary use, and are not intended to diagnose, treat, cure or prevent any condition. Nothing on this page constitutes medical advice or guidance for use in humans.<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>M\u00eame institut, m\u00eame conception stabilisatrice, mol\u00e9cules parentes et voies diff\u00e9rentes. Une comparaison directe des deux peptides nootropiques russes, et pourquoi ils sont \u00e9tudi\u00e9s ensemble.<\/p>","protected":false},"author":1,"featured_media":1281,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"_kad_post_transparent":"","_kad_post_title":"","_kad_post_layout":"","_kad_post_sidebar_id":"","_kad_post_content_style":"","_kad_post_vertical_padding":"","_kad_post_feature":"","_kad_post_feature_position":"","_kad_post_header":false,"_kad_post_footer":false,"_kad_post_classname":"","_vistara_fr_title":"","_vistara_fr_desc":"","_vl_research_product":52,"footnotes":""},"categories":[33],"tags":[],"vl_research_area":[39],"class_list":["post-1183","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-peptide-research"],"_links":{"self":[{"href":"https:\/\/vistaralabs.ca\/fr\/wp-json\/wp\/v2\/posts\/1183","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vistaralabs.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/vistaralabs.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/vistaralabs.ca\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/vistaralabs.ca\/fr\/wp-json\/wp\/v2\/comments?post=1183"}],"version-history":[{"count":4,"href":"https:\/\/vistaralabs.ca\/fr\/wp-json\/wp\/v2\/posts\/1183\/revisions"}],"predecessor-version":[{"id":1469,"href":"https:\/\/vistaralabs.ca\/fr\/wp-json\/wp\/v2\/posts\/1183\/revisions\/1469"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/vistaralabs.ca\/fr\/wp-json\/wp\/v2\/media\/1281"}],"wp:attachment":[{"href":"https:\/\/vistaralabs.ca\/fr\/wp-json\/wp\/v2\/media?parent=1183"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/vistaralabs.ca\/fr\/wp-json\/wp\/v2\/categories?post=1183"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vistaralabs.ca\/fr\/wp-json\/wp\/v2\/tags?post=1183"},{"taxonomy":"vl_research_area","embeddable":true,"href":"https:\/\/vistaralabs.ca\/fr\/wp-json\/wp\/v2\/vl_research_area?post=1183"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}